2-methylellipticinium has been researched along with ellipticine in 4 studies
| Studies (2-methylellipticinium) | Trials (2-methylellipticinium) | Recent Studies (post-2010) (2-methylellipticinium) | Studies (ellipticine) | Trials (ellipticine) | Recent Studies (post-2010) (ellipticine) |
|---|---|---|---|---|---|
| 12 | 0 | 0 | 454 | 0 | 178 |
| Protein | Taxonomy | 2-methylellipticinium (IC50) | ellipticine (IC50) |
|---|---|---|---|
| Cytochrome P450 1A1 | Homo sapiens (human) | 0.0193 | |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | 0.2 | |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | 3.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angelo, M; Fry, DW; Werbel, LM; Worth, DF | 1 |
| Auclair, C; Hyland, K; Paoletti, C | 1 |
| Auclair, C; Paoletti, C | 1 |
| Anderson, WK; Gopalsamy, A; Reddy, PS | 1 |
4 other study(ies) available for 2-methylellipticinium and ellipticine
| Article | Year |
|---|---|
Basically substituted ellipticine analogues as potential antitumor agents.
Topics: Alkaloids; Animals; Drug Evaluation, Preclinical; Ellipticines; Indicators and Reagents; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 1986 |
Autoxidation of the antitumor drug 9-hydroxyellipticine and its derivatives.
Topics: Alkaloids; Chemical Phenomena; Chemistry; Edetic Acid; Ellipticines; Kinetics; Manganese; Oxidation-Reduction; Oxygen Consumption; Spectrophotometry; Structure-Activity Relationship; Superoxide Dismutase | 1983 |
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
Topics: Alkaloids; Animals; Antineoplastic Agents; Biotransformation; Ellipticines; Hydrogen Peroxide; Mice; Oxidation-Reduction; Peroxidases; Structure-Activity Relationship | 1981 |
Design, synthesis, and study of 9-substituted ellipticine and 2-methylellipticinium analogues as potential CNS-selective antitumor agents.
Topics: Antineoplastic Agents; Central Nervous System Neoplasms; Drug Design; Drug Screening Assays, Antitumor; Ellipticines; Humans; Magnetic Resonance Spectroscopy; Structure-Activity Relationship; Tumor Cells, Cultured | 1994 |